TGTX
TG THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$56.87
+0.71%Forward multiples
Based on analyst estimates
- P/E forward
- 30.02x
- P/E 2026E
- 56.87x
- P/E 2027E
- 19.94x
- P/E 2028E
- 15.54x
- P/S forward
- 7.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.68x
- PEG TTM
- —
- Price / book
- 14.41x
- Price / sales
- 10.89x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $8.9B
- EV / sales
- 11.14x
- EV / EBITDA
- 66.39x
- EV / EBIT
- 65.34x
- Market cap
- $8.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026